To improve the surgical success and reduce the complication rates, we combine our routine preoperative ultrasound (US) mapping technique with radioguided occult lesion localization (ROLL) in patients with papillary thyroid cancer recurrences in central compartment. In the morning of surgery, biopsy proven recurrent/persistent tumoral lesions were plotted on a sketch and injected with Tc-99m labeled macroaggregated albumin under US guidance. Thyroid bed exploration was carried out based on the location of biopsy proven lesion with the guidance of intraoperative gamma probe and neck map. The lymphoadipose tissues showing high count rates were resected and labeled separately for histopathologic study. Despite extensive scarring in some patients probe safely guided to lesions. Noninjected tumor foci were searched and successfully resected in the light of neck map that showing topographic relation of injected and noninjected lesions. Among total of 41 excised lesions, 28 metastatic foci ranging from 3 to 38 mm in largest diameter were recognized at final histologic examination. Combination of preoperative mapping with ROLL was found helpful by the operating surgeons in all patients, respectively. Except 2 patients with known distant metastases, undetectable thyroglobulin levels were reached 6 weeks after surgery. The use of preoperative US-mapping with ROLL in patients with nonpalpable recurrent/persistent papillary thyroid cancer in central compartment is technically safe and effective method. Combination of techniques provides better information about topographical relations of recurrent/persistent lesions during surgery.
A 62-year-old man with transitional-cell carcinoma of the bladder had undergone transurethral resection and adjuvant treatment with several intravesical instillations of bacillus Calmette-Guerin 10 months earlier. The patient was referred for F-18 FDG PET/CT after detection of mediastinal lymphadenopathy on follow-up CT. Beside moderately increased FDG uptake in bilateral hilar and bronchopulmonary lymph nodes, focally intense FDG uptake was detected in the right lobe of the prostate. Histopathologic evaluation revealed granulomatous prostatitis which is a recognized rare complication of intravesical instillation of BCG during the treatment of superficial bladder cancer.